Evoke Pharma Inc Quarterly Common Stock, Shares, Outstanding from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Evoke Pharma Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2012 to Q3 2024.
  • Evoke Pharma Inc Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 895K shares, a 73.2% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 895K -2.45M -73.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 735K -2.61M -78% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 8.6M +5.25M +157% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 279K -3.06M -91.7% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 3.34M 0 0% Sep 30, 2023 10-K/A 2024-05-14
Q2 2023 3.34M 0 0% Jun 30, 2023 10-K/A 2024-05-14
Q1 2023 3.34M -29.6M -89.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 3.34M +622K +22.8% Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 3.34M -29.3M -89.8% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 3.34M -29.1M -89.7% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 32.9M +546K +1.69% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 2.72M -23.9M -89.8% Dec 31, 2021 10-K 2023-03-21
Q3 2021 32.7M +6.32M +24% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 32.4M +6.43M +24.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 32.4M +7.92M +32.4% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 26.6M +2.19M +8.96% Dec 31, 2020 10-K 2022-03-08
Q3 2020 26.3M +2.1M +8.67% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 26M +1.9M +7.87% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 24.5M +6.58M +36.8% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 24.4M +7M +40.2% Dec 31, 2019 10-K 2021-03-11
Q3 2019 24.2M +6.8M +39% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 24.1M +7.22M +42.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 17.9M +2.2M +14% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 17.4M +2.01M +13.1% Dec 31, 2018 10-K 2020-03-12
Q3 2018 17.4M +2.01M +13.1% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 16.9M +1.51M +9.82% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 15.7M +294K +1.91% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 15.4M +3.06M +24.8% Dec 31, 2017 10-K 2019-03-06
Q3 2017 15.4M +3.06M +24.8% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 15.4M +8.1M +111% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 15.4M +8.15M +113% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 12.4M +5.15M +71.5% Dec 31, 2016 10-K 2018-03-07
Q3 2016 12.4M +5.26M +74.3% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 7.29M +986K +15.6% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 7.24M +1.04M +16.7% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 7.2M +1.09M +17.8% Dec 31, 2015 10-K 2017-03-15
Q3 2015 7.09M +973K +15.9% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 6.31M +207K +3.39% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 6.2M +99.4K +1.63% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 6.11M +15.3K +0.25% Dec 31, 2014 10-K 2016-03-10
Q3 2014 6.11M +330K +5.71% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 6.1M Jun 30, 2014 10-Q 2014-08-13
Q1 2014 6.1M Mar 31, 2014 10-Q 2014-05-13
Q4 2013 6.1M +4.85M +391% Dec 31, 2013 10-K 2015-03-04
Q3 2013 5.78M Sep 30, 2013 10-Q 2013-11-13
Q4 2012 1.24M Dec 31, 2012 10-K 2014-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.